Jon Napitupulu

Silo Pharma has moved a portion of its corporate treasury into the AlphaLedger/Simplify Target 12% Distribution Fund on the...

Collegium Pharmaceutical has launched a high-profile awareness collaboration with Paris Hilton centered on adult ADHD, with plans for Hilton...

Medicus Pharma has entered a strategic collaboration with the Gorlin Syndrome Alliance to pursue an Expanded Access IND for...

Kamada will brief investors at the Stifel 2025 Healthcare Conference in New York on November 12 at 9:20 a.m....

Seres Therapeutics has secured up to $3.6 million in additional non-dilutive funding from CARB-X to develop and manufacture an...

Fulcrum Therapeutics reported new Phase 1b data for its oral EED inhibitor, pociredir, in sickle cell disease, showing dose-dependent,...

ADMA Biologics will report third-quarter 2025 results on November 5, alongside a call to discuss performance across its plasma-derived...

OKYO Pharma will use next week’s BIO-Europe meeting in Vienna to spotlight urcosimod, its lipid-anchored chemerin receptor agonist, following...

Genfit will use AASLD The Liver Meeting 2025 to showcase breadth across its hepatology portfolio, led by new preclinical...

Tarsus Pharmaceuticals will host a live webcast on November 4 to report third-quarter 2025 results and deliver a corporate...